CL2008002853A1 -
Compounds derived from substituted pyraziin quinoline, macrophage migration inhibitors (mif); and its use in the treatment of inflammation, septic shock, arthritis, cancer, autoimmune disorders and inhibition of angiogenesis (divisional of application 1088-02)
- Google Patents
Compounds derived from substituted pyraziin quinoline, macrophage migration inhibitors (mif); and its use in the treatment of inflammation, septic shock, arthritis, cancer, autoimmune disorders and inhibition of angiogenesis (divisional of application 1088-02)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=51399105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008002853(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Avanir PharmaceuticalsfiledCriticalAvanir Pharmaceuticals
Publication of CL2008002853A1publicationCriticalpatent/CL2008002853A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Compuestos derivados de piraziin-quinolina sustituida, inhibidores de la migración de macrófagos (MIF); procedimiento de preparación; composición farmacéutica; y su uso en el tratamiento de inflamación, shock séptico, artritis, cáncer, trastornos autoinmunes e inhibición de angiogénesis.Compounds derived from substituted piraziin-quinoline, macrophage migration (MIF) inhibitors; preparation procedure; pharmaceutical composition; and its use in the treatment of inflammation, septic shock, arthritis, cancer, autoimmune disorders and inhibition of angiogenesis.
CL2008002853A2002-05-242008-09-25
Compounds derived from substituted pyraziin quinoline, macrophage migration inhibitors (mif); and its use in the treatment of inflammation, septic shock, arthritis, cancer, autoimmune disorders and inhibition of angiogenesis (divisional of application 1088-02)
CL2008002853A1
(en)
Compounds derived from substituted pyraziin quinoline, macrophage migration inhibitors (mif); and its use in the treatment of inflammation, septic shock, arthritis, cancer, autoimmune disorders and inhibition of angiogenesis (divisional of application 1088-02)
COMPOUNDS DERIVED FROM DIAMINOTRIAZOLS, INHIBITORS D ELA PROTEINA QUINASA; PHARMACEUTICAL COMPOSITION; PREPARATION PROCEDURE; AND ITS USE OF THE COMPOUND IN THE TREATMENT OF DISEASES OF ALLERGIC DISORDERS, PROLIFERATION, AUTOIMMUNES, CONDIC
Use of osteopontin for the treatment and / or prevention of neurological diseases, as well as a pharmaceutical composition comprising osteopontin or an antagonist with osteopontin activity.
USE OF INHIBITORS OF THE PRODUCTION AND / OR ACTION OF IL-18 AND PHARMACEUTICAL COMPOSITIONS FORMULATED WITH SUCH INHIBITORS FOR THE TUMORS DEMETASTASIS TREATMENT.